Gastroenterology
Volume 132, Issue 3 , Pages 905-912 , March 2007

A Functional Polymorphism of Toll-Like Receptor 4 Gene Increases Risk of Gastric Carcinoma and Its Precursors

  • Georgina L. Hold

      Affiliations

    • Department of Medicine and Therapeutics, Aberdeen University, Aberdeen, Scotland
    • ,
  • Charles S. Rabkin

      Affiliations

    • Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland
    • ,
  • Wong–Ho Chow

      Affiliations

    • Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland
    • ,
  • Malcolm G. Smith

      Affiliations

    • Department of Medicine and Therapeutics, Aberdeen University, Aberdeen, Scotland
    • ,
  • Marilie D. Gammon

      Affiliations

    • Department of Epidemiology, University of North Carolina, Chapel Hill, North Carolina
    • ,
  • Harvey A. Risch

      Affiliations

    • Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, Connecticut
    • ,
  • Thomas L. Vaughan

      Affiliations

    • Program in Epidemiology, Fred Hutchinson Cancer Research Center, and Department of Epidemiology, University of Washington School of Public Health, Seattle, Washington
    • ,
  • Kenneth E.L. McColl

      Affiliations

    • Department of Medicine and Therapeutics, Glasgow University, Western Infirmary, Glasgow, UK
    • ,
  • Jolanta Lissowska

      Affiliations

    • Division of Cancer Epidemiology and Prevention, Cancer Centre and M. Sklodowska-Curie Institute of Oncology, Warsaw, Poland
    • ,
  • Witold Zatonski

      Affiliations

    • Division of Cancer Epidemiology and Prevention, Cancer Centre and M. Sklodowska-Curie Institute of Oncology, Warsaw, Poland
    • ,
  • Janet B. Schoenberg

      Affiliations

    • Applied Cancer Epidemiology Program, New Jersey Department of Health and Senior Services, Trenton, New Jersey
    • ,
  • William J. Blot

      Affiliations

    • International Epidemiology Institute, Rockville, Maryland
    • ,
  • N. Ashley G. Mowat

      Affiliations

    • Department of Medicine and Therapeutics, Aberdeen University, Aberdeen, Scotland
    • ,
  • Joseph F. Fraumeni Jr

      Affiliations

    • Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland
    • ,
  • Emad M. El–Omar

      Affiliations

    • Department of Medicine and Therapeutics, Aberdeen University, Aberdeen, Scotland
    • Corresponding Author InformationAddress requests for reprints to: Professor Emad M. El-Omar, MD, Department of Medicine and Therapeutics, Aberdeen University, Institute of Medical Sciences, Foresterhill, Aberdeen, AB25 2ZD, Scotland. fax: (44) 1224-555766.

Received 16 January 2006 ,Accepted 30 November 2006.

References 

  1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74–108
  2. Suerbaum S, Michetti P. Helicobacter pylori infection. N Engl J Med. 2002;347:1175–1186
  3. Peek RM, Blaser MJ. Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nat Rev Cancer. 2002;2:28–37
  4. Macarthur M, Hold GL, El-Omar EM. Inflammation and Cancer II (Role of chronic inflammation and cytokine gene polymorphisms in the pathogenesis of gastrointestinal malignancy). Am J Physiol Gastrointest Liver Physiol. 2004;286:G515–G520
  5. El-Omar EM, Carrington M, Chow WH, McColl KE, Bream JH, Young HA, et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature. 2000;404:398–402
  6. El-Omar EM, Rabkin CS, Gammon MD, Vaughan TL, Risch HA, Schoenberg JB, et al. Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms. Gastroenterology. 2003;124:1193–1201
  7. Machado JC, Pharoah P, Sousa S, Carvalho R, Oliveira C, Figueiredo C, et al. Interleukin 1B and interleukin 1RN polymorphisms are associated with increased risk of gastric carcinoma. Gastroenterology. 2001;121:823–829
  8. Figueiredo C, Machado JC, Pharoah P, Seruca R, Sousa S, Carvalho R, et al. Helicobacter pylori and interleukin 1 genotyping: an opportunity to identify high-risk individuals for gastric carcinoma. J Natl Cancer Inst. 2002;94:1680–1687
  9. Machado JC, Figueiredo C, Canedo P, Pharoah P, Carvalho R, Nabais S, et al. A proinflammatory genetic profile increases the risk for chronic atrophic gastritis and gastric carcinoma. Gastroenterology. 2003;125:364–371
  10. Segal ED, Lange C, Covacci A, Tompkins LS, Falkow S. Induction of host signal transduction pathways by Helicobacter pylori. Proc Natl Acad Sci U S A. 1997;94:7595–7599
  11. Pasare C, Medzhitov R. Toll-like receptors: linking innate and adaptive immunity. Adv Exp Med Biol. 2005;560:11–18
  12. Takeda K, Akira S. Toll-like receptors in innate immunity. Int Immunol. 2005;17:1–14
  13. Arbour NC, Lorenz E, Schutte BC, Zabner J, Kline JN, Jones M, et al. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet. 2000;25:187–191
  14. Zheng SL, Augustsson-Balter K, Chang B, Hedelin M, Li L, Adami HO, et al. Sequence variants of toll-like receptor 4 are associated with prostate cancer risk: results from the Cancer Prostate in Sweden Study. Cancer Res. 2004;64:2918–2922
  15. Chen YC, Giovannucci E, Lazarus R, Kraft P, Ketkar S, Hunter DJ. Sequence variants of Toll-like receptor 4 and susceptibility to prostate cancer. Cancer Res. 2005;65:11771–11778
  16. Hellmig S, Fischbach W, Goebeler-Kolve ME, Folsch UR, Hampe J, Schreiber S. Association study of a functional Toll-like receptor 4 polymorphism with susceptibility to gastric mucosa-associated lymphoid tissue lymphoma. Leuk Lymphoma. 2005;46:869–872
  17. Franchimont D, Vermeire S, El Housni H, Pierik M, Van Steen K, Gustot T, et al. Deficient host-bacteria interactions in inflammatory bowel disease? (The toll-like receptor (TLR)-4 Asp299gly polymorphism is associated with Crohn’s disease and ulcerative colitis). Gut. 2004;53:987–992
  18. Lorenz E, Mira JP, Frees KL, Schwartz DA. Relevance of mutations in the TLR4 receptor in patients with gram-negative septic shock. Arch Intern Med. 2002;162:1028–1032
  19. Kiechl S, Lorenz E, Reindl M, Wiedermann CJ, Oberhollenzer F, Bonora E, et al. Toll-like receptor 4 polymorphisms and atherogenesis. N Engl J Med. 2002;347:185–192
  20. Higgins SC, Lavelle EC, McCann C, Keogh B, McNeela E, Byrne P, et al. Toll-like receptor 4-mediated innate IL-10 activates antigen-specific regulatory T cells and confers resistance to Bordetella pertussis by inhibiting inflammatory pathology. J Immunol. 2003;171:3119–3127
  21. Price AB. The Sydney System: histological division. J Gastroenterol Hepatol. 1991;6:209–222
  22. El-Omar EM, Oien K, Murray LS, El Nujumi A, Wirz A, Gillen D, et al. Increased prevalence of precancerous changes in relatives of gastric cancer patients: critical role of H. pylori. Gastroenterology. 2000;118:22–30
  23. Chow WH, Swanson CA, Lissowska J, Groves FD, Sobin LH, Nasierowska-Guttmejer A, et al. Risk of stomach cancer in relation to consumption of cigarettes, alcohol, tea and coffee in Warsaw, Poland. Int J Cancer. 1999;81:871–876
  24. Gammon MD, Schoenberg JB, Ahsan H, Risch HA, Vaughan TL, Chow WH, et al. Tobacco, alcohol, and socioeconomic status and adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst. 1997;89:1277–1284
  25. Lorenz E, Frees KL, Schwartz DA. Determination of the TLR4 genotype using allele-specific PCR. Biotechniques. 2001;31:22–24
  26. Royall RM. Model robust confidence intervals using maximum likelihood estimators. Int Stat Rev. 1986;54:221–226
  27. Ouburg S, Mallant-Hent R, Crusius JB, van Bodegraven AA, Mulder CJ, Linskens R, et al. The toll-like receptor 4 (TLR4) Asp299Gly polymorphism is associated with colonic localisation of Crohn’s disease without a major role for the Saccharomyces cerevisiae mannan-LBP-CD14-TLR4 pathway. Gut. 2005;54:439–440
  28. Tal G, Mandelberg A, Dalal I, Cesar K, Somekh E, Tal A, et al. Association between common Toll-like receptor 4 mutations and severe respiratory syncytial virus disease. J Infect Dis. 2004;189:2057–2063
  29. Kurt-Jones EA, Popova L, Kwinn L, Haynes LM, Jones LP, Tripp RA, et al. Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat Immunol. 2000;1:398–401
  30. Janeway CA, Medzhitov R. Innate immune recognition. Annu Rev Immunol. 2002;20:197–216
  31. Viala J, Chaput C, Boneca IG, Cardona A, Girardin SE, Moran AP, et al. Nod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island. Nat Immunol. 2004;5:1166–1174
  32. Kawahara T, Kuwano Y, Teshima-Kondo S, Sugiyama T, Kawai T, Nikawa T, et al. Helicobacter pylori lipopolysaccharide from type I, but not type II strains, stimulates apoptosis of cultured gastric mucosal cells. J Med Invest. 2001;48:167–174
  33. Schmausser B, Andrulis M, Endrich S, Lee SK, Josenhans C, Muller-Hermelink HK, et al. Expression and subcellular distribution of toll-like receptors TLR4, TLR5 and TLR9 on the gastric epithelium in Helicobacter pylori infection. Clin Exp Immunol. 2004;136:521–526
  34. Schmausser B, Andrulis M, Endrich S, Muller-Hermelink HK, Eck M. Toll-like receptors TLR4, TLR5 and TLR9 on gastric carcinoma cells: an implication for interaction with Helicobacter pylori. Int J Med Microbiol. 2005;295:179–185
  35. Backhed F, Rokbi B, Torstensson E, Zhao Y, Nilsson C, Seguin D, et al. Gastric mucosal recognition of Helicobacter pylori is independent of Toll-like receptor 4. J Infect Dis. 2003;187:829–836
  36. Smith MF, Mitchell A, Li G, Ding S, Fitzmaurice AM, Ryan K, et al. Toll-like receptor (TLR) 2 and TLR5, but not TLR4, are required for Helicobacter pylori-induced NF-kappa B activation and chemokine expression by epithelial cells. J Biol Chem. 2003;278:32552–32560
  37. Lepper PM, Triantafilou M, Schumann C, Schneider EM, Triantafilou K. Lipopolysaccharides from Helicobacter pylori can act as antagonists for Toll-like receptor 4. Cell Microbiol. 2005;7:519–528
  38. Mandell L, Moran AP, Cocchiarella A, Houghton J, Taylor N, Fox JG, et al. Intact Gram-negative Helicobacter pylori, Helicobacter felis, and Helicobacter hepaticus bacteria activate innate immunity via toll-like receptor 2 but not toll-like receptor 4. Infect Immun. 2004;72:6446–6454
  39. Pasterkamp G, Van Keulen JK, De Kleijn DP. Role of Toll-like receptor 4 in the initiation and progression of atherosclerotic disease. Eur J Clin Invest. 2004;34:328–334

 Supported by a grant from Cancer Research UK (C8969/A3868), and by the Intramural Research Program of the National Cancer Institute, National Institutes of Health.

PII: S0016-5085(06)02676-X

doi: 10.1053/j.gastro.2006.12.026

Gastroenterology
Volume 132, Issue 3 , Pages 905-912 , March 2007

Article Tools

* Image Usage & Resolution